Index of reports
> Disability (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nevanac (Nepafenac Ophthalmic) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Nevanac side effects in 56 year old male
Reported by a physician from Japan on 2012-04-02
Patient: 56 year old male
Reactions: Corneal Exfoliation, Ulcerative Keratitis, Visual Acuity Reduced, Corneal Opacity
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Nevanac
Dosage: (1 gtt tid ou ophthalmic), (1 gtt qid os ophthalmic)
Indication: Postoperative Care
Start date: 2011-08-05
End date: 2011-11-04
Nevanac
Dosage: (1 gtt tid ou ophthalmic), (1 gtt qid os ophthalmic)
Indication: Postoperative Care
Start date: 2011-06-29
End date: 2011-07-14
|